SELLAS Life Sciences Group, Inc. Deferred Tax Assets, Other Tax Carryforwards
SELLAS Life Sciences Group, Inc. (SLS) had Deferred Tax Assets, Other Tax Carryforwards of $324.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOtherTaxCarryforwards · last filed 2025-03-20
- 2024-12-31: Deferred Tax Assets, Other Tax Carryforwards $324.00K.
- 2023-12-31: Deferred Tax Assets, Other Tax Carryforwards $297.00K.
- 2022-12-31: Deferred Tax Assets, Other Tax Carryforwards $282.00K.
- 2021-12-31: Deferred Tax Assets, Other Tax Carryforwards $217.00K.
| Period end | Deferred Tax Assets, Other Tax Carryforwards | Deferred Tax Assets, Other Tax Carryforwards as first filed |
|---|---|---|
| 2024-12-31 | $324.00K 10-K · filed 2025-03-20 | |
| 2023-12-31 | $297.00K 10-K · filed 2025-03-20 | |
| 2022-12-31 | $282.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $217.00K 10-K · filed 2023-03-16 | |
| 2020-12-31 | $190.00K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $27.00K 10-K · filed 2021-03-23 | |
| 2018-12-31 | $56.00K 10-K · filed 2020-03-13 | |
| 2017-12-31 | $395.00K 10-K · filed 2019-03-22 | |
| 2016-12-31 | $81.00K 10-K · filed 2018-04-13 | $58.00K 10-K · filed 2017-03-15 |
| 2015-12-31 | $1.43M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $190.00K 10-K/A · filed 2016-04-15 | |
| 2013-12-31 | $12.00K 8-K · filed 2015-12-04 | |
| 2012-12-31 | -$328.00K 10-K · filed 2014-03-17 | |
| 2011-12-31 | $193.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |